Exempt, expedited or full board at Chamberlain: which review path your project is on
Your review path is assigned rather than chosen, and at Chamberlain the starting assumption is stricter than most people expect. Its IRB Handbook states that the chair determines the pathway for every proposal, and that by default proposals are reviewed by all IRB members — full board — with exempt, limited and expedited review available as alternatives when the criteria are met. The good news sits one step earlier: most DNP projects never reach this question at all, because prescreening closes them as work that is not human subjects research.
Four outcomes, not three. Most Chamberlain DNP projects close at prescreening as not human subjects research. Where review does apply, the path is exempt, expedited or full board — set by risk and design, not by preference, and each board decides for itself.
Why is "not research" the first branch, not a review path?
Because the exempt, expedited and full board categories all sit inside the regulations. They describe how regulated human subjects research gets reviewed. If an activity is not research, or does not involve human subjects, it never enters that scheme.
This is the branch most Chamberlain DNP projects take. Chamberlain's handbook says most will meet the prescreening criteria for a determination that the project does not constitute human subjects research, and so most will not submit the full IRB application package. That is a fourth outcome, and in practice it is the most common one. How that determination is reached — and the three published triggers that can move a project out of it — is covered in the article on QI, research and the determination.
So read the paths below as the map for the exception rather than the rule: the project whose intervention is untested in its population, the one that adds a survey feeding an outward-facing claim, or the one whose site board takes a stricter view than the school did.
What do the review paths actually mean?
| Path | What it means | Where DNP work tends to land |
|---|---|---|
| Not human subjects research | Outside the regulations entirely — no review path applies. At Chamberlain this is reached through prescreening. | The expected outcome for most evidence-based practice-change projects. |
| Exempt | Research that falls in one of eight categories at 45 CFR 46.104. Exempt does not mean unreviewed — someone other than the investigator makes the determination. | Anonymous staff surveys; secondary analysis of records that are already de-identified or otherwise qualify. |
| Limited IRB review | A narrow review used to qualify certain exempt categories, focused mainly on privacy and confidentiality protections. | Identifiable survey data, or storage of identifiable information for later use. |
| Expedited | Minimal-risk research fitting a published category, reviewed by the chair or designated experienced reviewers rather than the convened board. | Chart review, recordings, interviews and focus groups where risk is minimal. |
| Full board | Review by the convened committee. Chamberlain's stated default for proposals submitted to it. | Greater-than-minimal-risk designs, vulnerable populations, or anything that does not clearly fit elsewhere. |
Paths as defined in 45 CFR 46 and as described in Chamberlain's IRB Handbook. Which path applies to your project is determined by the board, not by you.
What does "exempt" actually exempt you from?
Not from oversight, and not from ethics. The eight categories at 45 CFR 46.104 exempt certain research from most of the Common Rule's requirements, but two things remain true. The determination is not yours to make — an exemption asserted by the investigator is an opinion until a reviewer records it. And several categories only qualify by way of specific conditions, some of which require limited IRB review focused on whether privacy and confidentiality provisions are adequate.
Two categories matter most for practice-change work. Category 2 covers educational tests, surveys, interviews and observation of public behaviour, qualifying where responses carry no ready identifiers, or where disclosure could not sensibly expose someone to liability or harm their standing, employment, reputation or advancement — or, for identifiable information, by way of limited IRB review. Category 4 covers secondary research on identifiable information or biospecimens where, among other routes, the material is already public, or the investigator records it without identifiers and never re-identifies anyone, or it is used under the health care operations or research provisions of HIPAA.
Read category 2's middle condition carefully, because it is the one that fails in workplace projects. Surveying colleagues about a process on their own unit is exactly the setting where a disclosure could bear on employability or standing. That is a live consideration when you are studying the people you work beside, and it is why identifiability is worth designing out early rather than defending later.
What qualifies for expedited review?
Two conditions together: the research must present no more than minimal risk, and it must fit a category on the list the Secretary publishes. That list has been in force since 1998 and remains the operative one.
The categories that recur in DNP work are few. Category 5 covers research using data, documents or records already collected, or to be collected, for non-research purposes such as clinical care — the chart-review category. Category 6 reaches recordings — voice, video, digital or image — created for research. Category 7 covers research on individual or group characteristics or behaviour, and studies using survey, interview, focus group and programme evaluation methods. Categories 1 to 7 apply to initial and continuing review; 8 and 9 apply to continuing review only.
Three caveats matter. Appearing on the list does not by itself make a project minimal risk — that judgement is made separately. Expedited review is off the table where naming participants could realistically expose them to criminal or civil liability, or harm their finances, employment, insurability or reputation, unless protections are adequate. And consent obligations do not soften because the review is expedited.
There is one structural protection worth knowing. Under 45 CFR 46.110 the reviewers acting on an expedited basis may approve or require modifications, but they may not disapprove the research; a disapproval requires the convened board. So an expedited reviewer with concerns returns the file. That is the only move available, which is why a return should be read as a request rather than a verdict.
What is the convened board actually deciding?
The criteria are the same regardless of the path, and Chamberlain restates them in its own handbook. Risks minimised through sound design. Risks reasonable in relation to anticipated benefits and the importance of the knowledge expected — judged on the research itself, not on the long-range effects of applying what is learned. Equitable selection of participants. Consent sought from each participant or their legally authorised representative, and documented unless waived. Adequate provision for data security. Adequate protection of privacy and confidentiality. Additional safeguards where participants may be vulnerable to coercion or undue influence.
Most returns we see are not disagreements about ethics. They are one of those findings the board cannot yet make from what is in front of it — a data plan that does not say where identifiers live, a consent sheet that omits an element, a recruitment script that reads as pressure because the person recruiting manages the people being recruited.
What moves a project from one path to another?
- Identifiability. The single biggest lever. Identifiable data pulls a project toward limited or expedited review and is the line most site boards attend to first.
- Who the participants are. Vulnerability and the potential for coercion or undue influence pull toward full board, and they arrive quietly in workplace projects where the investigator has authority over the participants.
- What the intervention is. Applying established evidence reads differently from testing something untested — which is where the determination question and the path question meet.
- What you will collect beyond the operational data. A survey or interview layer added to an operational change is frequently what introduces a review path at all.
- Whether risk exceeds minimal. Beyond minimal risk, expedited review is unavailable by definition.
Does the site board use the same categories?
Often, but not always, and never on your schedule. A hospital IRB operating under its own Federalwide Assurance works from the same regulatory scheme, so exempt and expedited will be familiar terms. A nursing research council or an operational review committee may run a process of its own design with its own labels.
What does not travel is the conclusion. Chamberlain's determination binds Chamberlain's board; a site's determination binds the site's. The same file can be prescreened out at the school and convened at the site, which is precisely why we write the consent materials and data plan to the stricter of the two readings. The ordering consequences are set out in the piece on opening the site's board first.
What to do next
Stop trying to predict your path and start reducing what determines it. Ask three questions of your design today: does anything I collect carry identifiers, could disclosure affect anyone's standing at work, and is my intervention genuinely established in the population I will deliver it to? Honest answers to those three tell you more about your likely path than any category list.
Then request the free application review. We read the project against both tracks and tell you, in writing, how each board is likely to classify it, what would move it, and what the file needs to support the classification you are claiming. Shorter questions are answered on the FAQ. The classification belongs to each board; what we control is whether the file supports it.
Sources
- Chamberlain's board handbook — pathways assigned by the chair, the convened committee as its starting position, and its restatement of the findings required — Chamberlain IRB Handbook (PDF)
- Chamberlain's current DNP handbook (©2026) — the prescreening expectation, and the three levels it names — DNP Project & Practicum Handbook (PDF)
- The categories that carry an exemption — 45 CFR 46.104 (Cornell LII)
- Expedited procedure, and the rule that a designated reviewer may approve but never refuse — 45 CFR 46.110 (Cornell LII)
- The findings a board must reach before it approves anything — 45 CFR 46.111 (Cornell LII)
- The published expedited list still in force, 63 FR 60353 (9 November 1998) — Federal Register, via govinfo
Review pathways are assigned by each board under its own procedures. Chamberlain's current handbook or IRB portal is the authority here; where it departs from anything on this page, follow Chamberlain. This is an independent practice, unaffiliated with Chamberlain University.